These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11558458)

  • 21. [Clinico-microbiological trial of the preparation pinol A].
    Katranushkova N; Zlatkov V; Katsarova M
    Akush Ginekol (Sofiia); 1988; 27(5):48-51. PubMed ID: 3223559
    [No Abstract]   [Full Text] [Related]  

  • 22. The impact of microbicides and changes in condom usage on HIV prevalence in men and women.
    Chen FH
    AIDS; 2006 Jul; 20(11):1551-3. PubMed ID: 16847411
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanoparticles deliver a sting to HIV‑1 infectivity.
    Potticary J
    Nanomedicine (Lond); 2013 May; 8(5):684-5. PubMed ID: 23802267
    [No Abstract]   [Full Text] [Related]  

  • 24. [Effects of nonoxinol 9 on RFLP typing of postcoital vaginal smears].
    Hochmeister M; Miescher E; Lipowec W; Borer UV; Dirnhofer R
    Beitr Gerichtl Med; 1992; 50():95-8. PubMed ID: 1362645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Vaginal microbicides.
    O'Brien RF
    Adolesc Med Clin; 2006 Oct; 17(3):673-85; abstract xi. PubMed ID: 17030285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antiviral contraceptive gel wins Gates Foundation grant.
    AIDS Patient Care STDS; 2011 Feb; 25(2):128-9. PubMed ID: 21370525
    [No Abstract]   [Full Text] [Related]  

  • 27. Glyminox Biosyn.
    Witherell GW
    Curr Opin Investig Drugs; 2004 Feb; 5(2):222-31. PubMed ID: 15043398
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The need for a "condoms-only" control group in microbicide trials.
    Jones H; van de Wijgert J; Kelvin E
    Epidemiology; 2003 Jul; 14(4):505; author reply 505-6. PubMed ID: 12843779
    [No Abstract]   [Full Text] [Related]  

  • 29. Recurrent bacterial vaginosis: the use of maintenance acidic vaginal gel following treatment.
    Wilson JD; Shann SM; Brady SK; Mammen-Tobin AG; Evans AL; Lee RA
    Int J STD AIDS; 2005 Nov; 16(11):736-8. PubMed ID: 16303068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Care should be taken when promoting microbicide use among sex workers who are able to use condoms consistently: response to Smith et al. (2005).
    Foss AM; Watts CH; Vickerman PT; Heise L
    AIDS; 2006 Jan; 20(2):303-5. PubMed ID: 16511432
    [No Abstract]   [Full Text] [Related]  

  • 31. A vaginal prosthetic device as an aid in treating ulcerative lichen planus of the mucous membrane. Successful combination therapy with a corticosteroid-bioadhesive compound and iontophoresis.
    Walsh DS; Dunn CL; Konzelman J; Sau P; James WD
    Arch Dermatol; 1995 Mar; 131(3):265-7. PubMed ID: 7887654
    [No Abstract]   [Full Text] [Related]  

  • 32. [Inducing labor applying intra-cervical prostaglandin E vaginal tablets].
    Minkov R; Popova A; Kovachev E; Tsvetkova S; Protopopov F; Pencheva M
    Akush Ginekol (Sofiia); 2002; 41 Suppl 2():13-5. PubMed ID: 19708188
    [No Abstract]   [Full Text] [Related]  

  • 33. Challenges to microbicide introduction in South Africa.
    Orner P; Harries J; Cooper D; Moodley J; Hoffman M; Becker J; McGrory E; Dabash R; Bracken H
    Soc Sci Med; 2006 Aug; 63(4):968-78. PubMed ID: 16600447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaginal gel effective.
    AIDS Patient Care STDS; 2006 Jul; 20(7):529. PubMed ID: 16839252
    [No Abstract]   [Full Text] [Related]  

  • 35. Safety, tolerability, and systemic absorption of dapivirine vaginal microbicide gel in healthy, HIV-negative women.
    Nel AM; Coplan P; van de Wijgert JH; Kapiga SH; von Mollendorf C; Geubbels E; Vyankandondera J; Rees HV; Masenga G; Kiwelu I; Moyes J; Smythe SC
    AIDS; 2009 Jul; 23(12):1531-8. PubMed ID: 19550287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. PRO-2000, an antimicrobial gel for the potential prevention of HIV infection.
    Fletcher PS; Shattock RJ
    Curr Opin Investig Drugs; 2008 Feb; 9(2):189-200. PubMed ID: 18246522
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The epidemiology of new HIV infections and interventions to limit HIV transmission.
    Buchbinder S
    Top HIV Med; 2009; 17(2):37-43. PubMed ID: 19401606
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbicide preference among young women in California.
    Holt BY; Morwitz VG; Ngo L; Harrison PF; Whaley KJ; Pettifor A; Nguyen AH
    J Womens Health (Larchmt); 2006 Apr; 15(3):281-94. PubMed ID: 16620187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of Replens gel used with a diaphragm on tests for human papillomavirus and other lower genital tract infections.
    Smith-McCune KK; Tuveson JL; Rubin MM; Da Costa MM; Darragh TM; Shiboski SC; Van Der Pol B; Moscicki AB; Palefsky JM; Sawaya GF
    J Low Genit Tract Dis; 2006 Oct; 10(4):213-8. PubMed ID: 17012985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Response to Foss et al., 'Care should be taken when promoting microbicide use among sex workers who are able to use condoms consistently'.
    Wilson DP; Bodine EN; Smith RJ; Blower SM
    AIDS; 2005 Nov; 19(17):2044-6. PubMed ID: 16260916
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.